MARLBOROUGH, Mass.,
July 13, 2016 /PRNewswire/
-- Boston Scientific Corporation (NYSE: BSX) announced today
the election of Yoshiaki Fujimori to
its board of directors, effective immediately.
Yoshiaki Fujimori is an adviser
to the LIXIL Group Corporation ("LIXIL"), for which he served as
president and chief executive officer from 2011 to 2016. Prior to
joining LIXIL, Mr. Fujimori spent 25 years with GE, including
positions as senior vice president and chief executive officer
(CEO) of a number of Asian and global business divisions, including
Medical Systems, Plastics and Capital, and was a member of the
Corporate Executive Council before serving as chairman, president
and CEO of GE Japan for more than three years. Mr. Fujimori started
his career at Japanese trading company Nissho Iwai Corporation (now
Sojitz).
Mr. Fujimori serves as an external director of Tokyo Electric
Power Company, a role he has held since June
2012. He is also an external director for Takeda
Pharmaceutical Company Limited. He previously served as chairman of
the Japan Construction Material & Housing Equipment Industries
Federation. He received his bachelor's degree in petroleum
engineering from the University of
Tokyo and his master's degree from Carnegie Mellon Graduate
School of Business, where he serves as a lifetime member of the
Board of Trustees.
"Fujimori-san is an accomplished business leader and brings
significant insights on how large companies plan, execute and
compete globally to our Board," said Mike
Mahoney, chief executive officer and chairman of the board,
Boston Scientific. "We are delighted to welcome him to the
Board."
About Boston Scientific
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the world. As
a global medical technology leader for more than 35 years, we
advance science for life by providing a broad range of high
performance solutions that address unmet patient needs and reduce
the cost of healthcare. For more information, visit
www.bostonscientific.com and connect on Twitter and Facebook.
CONTACTS
|
|
Media:
|
Investors:
|
Kelly
Leadem
|
Susie Lisa,
CFA
|
508-683-5543
(office)
|
508- 683-5565
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
kelly.leadem@bsci.com
|
investor_relations@bsci.com
|
Photo - http://photos.prnewswire.com/prnh/20160712/388845
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/boston-scientific-elects-yoshiaki-fujimori-to-board-of-directors-300297688.html
SOURCE Boston Scientific Corporation